Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats (Q42465747)

1 November 2017

title

Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats (English)

1 reference

1 November 2017

1 reference

1 reference

Dachicourt N

1

1 reference

1 November 2017

Bailbé D

2

1 reference

1 November 2017

Gangnerau MN

3

1 reference

1 November 2017

Serradas P

4

1 reference

1 November 2017

Ravel D

5

1 reference

1 November 2017

Portha B

6

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

European Journal of Pharmacology

1 November 2017

published in

1 reference

1 November 2017

volume

361

1 reference

1 November 2017

issue

2-3

1 reference

1 November 2017

page(s)

243-251

1 reference

Synthesis of DNA in Isolated Pancreatic Islets Maintained in Tissue Culture

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Effect of Tolbutamide on Postnatal Neogenesis of the Islet of Langerhans in Mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Gliclazide on long-term therapy increases insulin response to glucose of type II diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

7 January 2021

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Effects of glibenclamide on pancreatic beta-cell proliferation in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Insulin, Proinsulin, Glucagon and Gastrin in Pancreatic Tumors and in Plasma of Patients with Organic Hyperinsulinism1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Modulation of rat pancreatic islet cell replication and insulin release by glibenclamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Experimental study on glibenclamide (HB 419), a new particularly active hypoglycaemic sulphonamide. II. Betacytotrophic action and stimulation of the neogenesis of the islets of Langerhans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Tissue Glycolytic and Gluconeogenic Enzyme Activities in Mildly and Moderately Diabetic Rats: Influence of Tolbutamide Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic beta cell in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Sulfonylureas stimulate glucose uptake through GLUT4 transporter translocation in rat skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Long-Term Actions of Sulfonylureas on (Pro-)Insulin Biosynthesis and Secretion - II. Studies after Administration of Tolbutamide and Glibenclamide to Rats In Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Reduction in the Activity of the Pancreatic Islets Induced in Normal Rodents by Prolonged Treatment with Derivatives of Sulfonylurea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Cholinergic agonists prime the beta-cell to glucose stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

Neuro-endocrine disorders seen as triggers of the triad: obesity--insulin resistance--abnormal glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900718-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00718-3

1 reference

1 November 2017

1 reference